Skip to content

Clinical trials

Completed Cholangiocarcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Status: Completed Country / region: United States Clear all

107 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20031
20082
20094
20112
20125
20136
20148
20155
20164
201713
201812
201912
20209
20219
20223
20234
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed107

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
Memorial Sloan Kettering Cancer Center5
Washington University School of Medicine4
Celldex Therapeutics3
City of Hope Medical Center3
Mayo Clinic3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
AbbVie2
Basilea Pharmaceutica2
Emory University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma107
Gallbladder Neoplasms22
Carcinoma, Hepatocellular21
Pancreatic Neoplasms21
Stomach Neoplasms21
Liver Neoplasms20
Colorectal Neoplasms19
Bile Duct Neoplasms17
Ovarian Neoplasms17
Carcinoma, Non-Small-Cell Lung14

Trials

Showing 1 to 25 of 107. Each trial links to its page on Pharma Observatory.

7 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.